Innovaccer's acquisition of CaduceusHealth for $66 million[1] is less a tuck-in and more a strategic reboot. Three days earlier, the company cut 340 employees—roughly 15% of its workforce—citing "tightening economics" in health-data aggregation. That framing set the stage for this move: data alone doesn't generate enough return; Innovaccer needs an autonomous, revenue-generating engine to justify its platform. The purchase pivots the company's narrative from "unified data" to "data-powered automation." RCM—the grunt work of claim processing, denial management, and payment collection—has long been an IT burden for health systems. Incumbents like Optum and change-of-control acquirers have held this turf; startups have pecked at the edges. But Innovaccer's angle is different: it owns a cross-payer, cross-provider data layer. If it can feed that data into agents that autonomously appeal denials, recode claims, and identify billing gaps, it flips the unit economics. Instead of selling "we gave you data," Innovaccer sells "we recovered X% of your lost revenue." That's a consumption-based moat, not a software-seat moat. The deeper move is defensive. Health-data aggregation became commodified faster than anyone expected—Verily, Nuance, and EHR incumbents all have data-harmonization layers now. Margins compressed; churn accelerated. Innovaccer's restructuring wasn't just cost-cutting; it was a signal that the company's previous path wasn't funding growth. The CaduceusHealth deal announces Plan B: embed downstream revenue recovery into the platform, own the outcome, and charge based on impact. If this works, the narrative shifts from "Innovaccer is a failing data startup" to "Innovaccer is an agentic RCM platform backed by unique data." That's a vastly different buyer profile—health systems care more about denials than dashboards—and a different unit economy.